These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10603563)

  • 1. Regulation of the immune response in experimental and human schistosomiasis: the limits of an attractive paradigm.
    Capron A; Dombrowicz D; Capron M
    Microbes Infect; 1999 Jun; 1(7):485-90. PubMed ID: 10603563
    [No Abstract]   [Full Text] [Related]  

  • 2. Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2?
    Wynn TA; Hoffmann KF
    Parasitol Today; 2000 Nov; 16(11):497-501. PubMed ID: 11063861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological aspects of human schistosomiasis.
    Butterworth AE
    Br Med Bull; 1998; 54(2):357-68. PubMed ID: 9830202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antigen-specific Th1-biased immune responses by plasmid DNA in schistosoma-infected mice with a preexistent dominant Th2 immune profile.
    Ayash-Rashkovsky M; Weisman Z; Zlotnikov S; Raz E; Bentwich Z; Borkow G
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1169-76. PubMed ID: 11302738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune biasing by helminth glycans.
    Thomas PG; Harn DA
    Cell Microbiol; 2004 Jan; 6(1):13-22. PubMed ID: 14678327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-mediated host responses during schistosome infections; walking the fine line between immunological control and immunopathology.
    Hoffmann KF; Wynn TA; Dunne DW
    Adv Parasitol; 2002; 52():265-307. PubMed ID: 12521263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris.
    Curry AJ; Else KJ; Jones F; Bancroft A; Grencis RK; Dunne DW
    J Exp Med; 1995 Feb; 181(2):769-74. PubMed ID: 7836929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunity in schistosomiasis].
    Shuĭkina EE; Osipova SO
    Med Parazitol (Mosk); 1993; (4):54-8. PubMed ID: 7968815
    [No Abstract]   [Full Text] [Related]  

  • 9. Th1-Th2: reliable paradigm or dangerous dogma?
    Allen JE; Maizels RM
    Immunol Today; 1997 Aug; 18(8):387-92. PubMed ID: 9267081
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.
    Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R
    Trop Geogr Med; 1994; 46(4 Spec No):242-6. PubMed ID: 7825228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine strategies against schistosomiasis: from concepts to clinical trials.
    Capron A; Capron M; Dombrowicz D; Riveau G
    Int Arch Allergy Immunol; 2001; 124(1-3):9-15. PubMed ID: 11306914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathology of schistosomiasis: a cautionary tale of mice and men.
    Fallon PG
    Immunol Today; 2000 Jan; 21(1):29-35. PubMed ID: 10637556
    [No Abstract]   [Full Text] [Related]  

  • 13. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.
    Nagayama Y; Watanabe K; Niwa M; McLachlan SM; Rapoport B
    J Immunol; 2004 Aug; 173(3):2167-73. PubMed ID: 15265954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine strategies against schistosomiasis.
    Capron A; Dessaint JP; Capron M; Pierce RJ
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():1-9. PubMed ID: 1342702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parasite glycans and antibody-mediated immune responses in Schistosoma infection.
    van Diepen A; Van der Velden NS; Smit CH; Meevissen MH; Hokke CH
    Parasitology; 2012 Aug; 139(9):1219-30. PubMed ID: 22423613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibody against schistosome and schistosome infection and reinfection].
    Li YF; Xie SY; Lin DD
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Apr; 24(2):217-21, 227. PubMed ID: 22799175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Th1/Th2 paradigm in allergic bronchopulmonary aspergillosis.
    Schuyler M
    J Lab Clin Med; 1998 Mar; 131(3):194-6. PubMed ID: 9523841
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunity in Filarial Infections: Lessons from Animal Models and Human Studies.
    Kwarteng A; Ahuno ST
    Scand J Immunol; 2017 Apr; 85(4):251-257. PubMed ID: 28168837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to schistosomes: progress toward vaccine.
    Capron A; Dessaint JP; Capron M; Ouma JH; Butterworth AE
    Science; 1987 Nov; 238(4830):1065-72. PubMed ID: 3317823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic cross-reactivity between Schistosoma mansoni and peanut: a role for cross-reactive carbohydrate determinants (CCDs) and implications for the hygiene hypothesis.
    Igetei JE; El-Faham M; Liddell S; Doenhoff MJ
    Immunology; 2017 Apr; 150(4):506-517. PubMed ID: 28201853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.